Dr. Anthony Vaccaro, MD

Dr. Vaccaro practices at Champlain Valley Physicians Hospital in Plattsburgh, New York, part of University of Vermont Health Network.

Dr. Vaccaro's NPI, 1790786051, was assigned on August 9, 2005. Dr. Vaccaro graduated from University of Pittsburgh School of Medicine in 1985. Dr. Vaccaro holds New York license 181259-1.

Dr. Vaccaro's primary practice is Champlain Valley Physicians Hospital, at 75 Beekman Street, Plattsburgh, NY 12901 in Clinton County. The practice phone is (518) 562-7767.

Dr. Vaccaro's primary practice is Champlain Valley Physicians Hospital in Plattsburgh, New York, part of University of Vermont Health Network. Dr. Vaccaro is also affiliated with University of Vermont Medical Center. The medical group on file is Alice Hyde Medical Center. Dmand AI also links Dr. Vaccaro to 3 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vaccaro practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Vaccaro's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Vaccaro is licensed in New York.

CMS data shows 3,802 Medicare services from Dr. Vaccaro across 20 procedure codes in 2024, for 238 Medicare patients. Medicare paid $230,940 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 238 Medicare patients who saw Dr. Vaccaro in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have cancer, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vaccaro's median patient age at 73, with 45% women.

In 2024, Dr. Vaccaro wrote 609 Medicare Part D claims for 146 patients. 90% of them were for generic drugs. CMS names the drug for 433 of them, across 17 drugs with 11 or more claims each, at $6,761 in total drug cost. In 2023, CMS named 415 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 46 out of 100 for Dr. Vaccaro for performance year 2024, reported individually. Dr. Vaccaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vaccaro as offering telehealth.

CMS Open Payments shows 4 general payments to Dr. Vaccaro from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $31.

Dr. Vaccaro graduated from University of Pittsburgh School of Medicine in 1985.